Analytical testing is a critical part in every step of drug development and manufacturing. The qualitative and quantitative results generated from validated analytical testing provide first-hand information to control and ensure the quality and safety of raw materials, intermediates, and finished products. Like many other CMC (chemical, manufacturing and control) activities, analytical testing is also frequently outsourced. Other services are stability testing by capillary electrophoresis services. Many factors are attributed to this rapid market growth, including continuous outsourcing from pharmaceutical companies, growing pipelines for biological candidates, and increasing demand for more analytical details on drugs and process development by regulatory agencies. In response to the changing market dynamics, service providers are striving to provide analytical testing with quality, accuracy, and robustness all within tight timelines. As the contract research organizations (CROs) have become more integrated, small analytical labs need to establish their niche to succeed. Global contract anlytical Laboratories provide QC laboratory analysis, method development, validation and expert advice for both finished products and raw materials for pharmaceutical and biopharmaceutical companies. Recently, the International Conference on Harmonisation (ICH) regulatory guideline QIA was revised (R2) when QIF “Stability Data Package for Registration Applications in Climatic Zones III and IV” was incorporated. The main changes included: Adjustment of intermediate storage conditions (previously 30°C ± 2°/60% RH ± 5%); acceptable relative humidity was changed to 65% ± 5% for drug substances, drug products and drug products packaged in semi-permeable containers, 30°C ± 2°/65% RH ± 5% can be used for long-term storage instead of 25°C ± 2°/60% RH ± 5% for drug substances and products, 30°C ± 2°/35% RH ± 5% can be used for long-term storage instead of 25°C ± 2°/40% RH ± 5% for drug products packaged in semi-permeable containers. Stability testing is required for all biopharmaceutical drug products to detect all changes in identity, purity, and potency as a result of a number of environmental and processing factors. Whether testing is conducted in-house or through contact laboratories, it involves the development and performance of comprehensive and specific stability protocols for all stages of a product’s life cycle. Testing product stability in-house requires significant time and resources, and carries challenges associated with commercialization market, time, and capacity. Stability assay methods should be specific enough to differentiate between analytes and possible degradation products. The overall quality of drug-substance and drug-product batches placed on formal stability studies should represent the quality of materials used in clinical studies and of the quality of materials to be made at manufacturing scale. Supporting stability data can be provided using stability data generated from batches of drug substances and drug products made on a laboratory scale. Stability studies also should be conducted on material stored in a container–closure system that is the same as (or simulates) packaging proposed for real storage and distribution. GMP Stability Services include cGMP registration stability programs, Design, storage and management, Development and validation of stability indicating methods, Stability testing for APIs, Clinical Trial Materials, formulated products, Tailored reporting (timepoint and final reports), All ICH conditions storage, Photostability (ICH Q1B Options 1 & 2), Temperature cycling, freeze-thaw and shipping studies, Bespoke or specialised conditions,Stability contingency and disaster recovery storage etc. Depending upon the aim and steps followed, stability testing procedures have been categorized into the following four types: Real-Time stability testing, Accelerated stability testing, Retained sample stability testing and Retained sample stability testing. Stability Studies are performed to understand the compounds/formulation in development: Physical & Chemical properties of API and drug product, Drug and excipient compatibility, Impact of manufacturing process steps, Interactions with packaging materials, Assignment of shelf life etc.

- Service Details

We perform ICH stability studies on drug substance and /or dosage form. Studies are conducted according to the Stability Study Protocols and fully under GMP conditions.

- Service Details

Quality Control Lab is equipped with HPLCs, GC Units with Head space for residual solvents, UV Spectrophotometer, FTIR Spectrophotometer, Particle Size analyzer (Malvern), Polarimeter, Walk-in type Stability Chamber, Modern Microbiological Lab.

- Service Details

We provide full analytical support including Analytical Method Transfer, Analytical Method Validation in accordance with ICH guidelines, Quality control & Release testing of raw materials & FDFs, Stability studies in different ICH storage conditions, etc

- Service Details

Besides performing all analytical tests demanded by the regulatory authorities for the respective API we also conduct stability studies and test for interactions with packaging materials or other materials that might come into contact with the active.

- Service Details

We provide ICH compliant stability control with a wide range of ICH conditions of walk in/reach in chambers, refrigerated & freezer storages with fully controlled and monitored.

- Service Details

We have extensive experience in the testing of drug products including preclinical prototype evaluation, Excipient compatibility, Finished product testing including purity, dissolution, physical characterization ICH stability testing of drug products.

- Service Details

Malladi’s R&D is well-equipped with a wide range of process and analytical capabilities such as method development and validation, stability including stability studies, photostabiltiy studies, stress testing and degradation profiling.

- Service Details

We support your API development & manufacturing requirements. Our CDMO Services include Solid State / Polymorphism Research, Characterization of Physical Properties, Particle Design, cGMP scale Up, Process Validation, Stability Studies etc

- Service Details

Gentec Pharmaceutical Group offers API, intermediates and HPAPIs developments and manufacture. We perform ICH stability studies on drug substance for our customers.

- Service Details

Our contract services group helps companies turn their new drug ideas into reality. Whether for phase I, phase II, phase III, or toxicology studies, we specialize in developing new synthetic routes while providing all necessary support to ensure regulatory compliance.

- Service Details

We also perform ICH compliant stability studies including stress studies, accelerated and long-term stability studies to support regulatory CMC programs and process development.

- Service Details

ScinoPharm's comprehensive analytical services include purity testing, characterization of polymorphs, analytic methods development & validation, & stability testing. All analytical instruments & data are managed through the company's LIMS.

- Service Details

Unither analytical services include methods development & validation, analytical methods transfer, ICH stability studies with storage, extractable & leachable closure system compatibility studies, unknown substance identification & characterization etc .

- Service Details

Uquifa offers the opportunity to manage the development activities of any drug life cycle by offering services on DMF/CTD/COS application, stability studies, process validation and analytical method validation, working standard supply or impurity

- Service Details

Dishman offers various analytical services under Stability which includes ICH Stability Studies, Stressing Studies, Photostability Studies, Drug Substance & Drug Product Stability and Degradation profiling.

- Service Details

Our R&D services include Drug substance, clinical trial materials, IND, NDA & ANDA registration stability testing, All ICH climatic stability zones, Photostability chamber, Forced degradation studies, Computerized data management & pull schedules, etc

- Service Details

Your GMP “One-Stop-Shop”, Angelini Fine Chemicals is a Contract Development and Manufacturing Organization (CDMO), which is fully dedicated to third party manufacturing of APIs, IMs and NCEs for the pharmaceutical and small molecule biotech industry.

- Service Details

The Formulation R & D Capability includes Design and development of new dosage forms, Pre formulation studies, Lab / pilot scale studies, Process optimization/validation studies, Stability studies as per ICH guidance, Technology transfer of new products.

- Service Details

We are undertaking contracts for Stability studies for APIs and Biotechnology products under various temperature conditions.

- Service Details

With Admix Pharma Laboratories, LLC you will enjoy a host of attractive benefits that can effectively extend your in-house pharmaceutical products development and manufacturing capabilities for long and short term projects.